Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:INBS NASDAQ:LYRA NASDAQ:MHUA NASDAQ:TIVC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINBSIntelligent Bio Solutions$2.13+12.1%$1.60$1.00▼$3.00$14.72M4.6572,310 shs778,716 shsLYRALyra Therapeutics$8.53+0.6%$9.99$3.81▼$37.50$11.30M0.24193,047 shs37,300 shsMHUAMeihua International Medical Technologies$0.43-1.1%$0.42$0.25▼$1.47$13.78M0.79687,622 shs26,208 shsTIVCTivic Health Systems$3.95+1.0%$4.04$2.43▼$16.08$3.48M1.99649,851 shs13,441 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINBSIntelligent Bio Solutions+9.83%+11.11%-0.52%+58.33%-1.55%LYRALyra Therapeutics-2.64%-8.32%-25.22%+84.35%-44.39%MHUAMeihua International Medical Technologies-1.55%+6.66%+28.29%+41.05%-51.86%TIVCTivic Health Systems-3.69%-5.56%+5.39%+6.25%-33.47%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINBSIntelligent Bio Solutions0.8879 of 5 stars0.03.00.00.02.80.01.3LYRALyra Therapeutics2.6681 of 5 stars3.22.00.00.02.42.51.3MHUAMeihua International Medical Technologies1.3211 of 5 stars0.03.00.00.03.81.70.6TIVCTivic Health Systems1.0913 of 5 stars0.05.00.00.02.70.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINBSIntelligent Bio Solutions 0.00N/AN/AN/ALYRALyra Therapeutics 2.33Hold$100.001,072.33% UpsideMHUAMeihua International Medical Technologies 0.00N/AN/AN/ATIVCTivic Health Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINBSIntelligent Bio Solutions$3.11M4.73N/AN/A$2.37 per share0.90LYRALyra Therapeutics$1.19M9.54N/AN/A$8.86 per share0.96MHUAMeihua International Medical Technologies$96.90M0.14$0.44 per share0.98$6.34 per share0.07TIVCTivic Health Systems$780K4.46N/AN/A$4.55 per share0.87Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINBSIntelligent Bio Solutions-$10.16MN/A0.006.09N/A-319.85%-176.55%-93.89%9/17/2025 (Estimated)LYRALyra Therapeutics-$93.43M-$60.50N/AN/AN/A-6,711.39%-295.52%-66.95%8/13/2025 (Estimated)MHUAMeihua International Medical Technologies$10.84MN/A0.00∞N/AN/AN/AN/AN/ATIVCTivic Health SystemsN/AN/A0.00∞N/A-4.07%-0.67%-0.57%8/13/2025 (Estimated)Latest TIVC, MHUA, INBS, and LYRA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025LYRALyra Therapeutics-$5.79N/AN/AN/A$0.18 millionN/A5/15/2025Q1 2025TIVCTivic Health SystemsN/A-$2.52N/A-$2.52N/A$0.07 million5/6/2025Q1 2025LYRALyra Therapeutics-$7.50-$6.00+$1.50-$0.13$0.16 million$0.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ALYRALyra TherapeuticsN/AN/AN/AN/AN/AMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/ATIVCTivic Health SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINBSIntelligent Bio SolutionsN/A1.120.97LYRALyra TherapeuticsN/A2.962.96MHUAMeihua International Medical TechnologiesN/A5.265.21TIVCTivic Health SystemsN/A1.701.29Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINBSIntelligent Bio Solutions32.97%LYRALyra Therapeutics95.62%MHUAMeihua International Medical Technologies1.17%TIVCTivic Health Systems4.25%Insider OwnershipCompanyInsider OwnershipINBSIntelligent Bio Solutions0.28%LYRALyra Therapeutics3.25%MHUAMeihua International Medical Technologies66.56%TIVCTivic Health Systems0.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINBSIntelligent Bio Solutions106.91 million6.89 millionNot OptionableLYRALyra Therapeutics501.33 million1.28 millionOptionableMHUAMeihua International Medical Technologies62031.90 million10.67 millionNot OptionableTIVCTivic Health Systems10880,000874,000Not OptionableTIVC, MHUA, INBS, and LYRA HeadlinesRecent News About These CompaniesTivic Health Systems (NASDAQ:TIVC) Trading Down 4.5% - Here's What HappenedJuly 12, 2025 | americanbankingnews.comTivic Health stock rises after shareholders approve strategic proposalsJuly 8, 2025 | in.investing.comTivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFOJuly 8, 2025 | finance.yahoo.comTivic Health Shares Gain Following Shareholder Approval of Strategic MovesJuly 8, 2025 | msn.comTivic Health Systems Inc (TIVC) - Investing.comJuly 5, 2025 | investing.comTivic Health Systems Inc News (TIVC) - Investing.comJuly 1, 2025 | investing.comTivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device - Business WireJune 26, 2025 | businesswire.comTivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation DeviceJune 25, 2025 | businesswire.comTivic Health Systems, Inc. (TIVC) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comTivic Health Announces 2025 Annual Meeting of StockholdersJune 24, 2025 | finance.yahoo.comTivic Health sets new deadlines for stockholder proposalsMay 21, 2025 | investing.comTivic Health Systems, Inc. (NASDAQ:TIVC) Q1 2025 Earnings Call TranscriptMay 17, 2025 | msn.comTivic Health’s Strategic Shift: Earnings Call InsightsMay 16, 2025 | tipranks.comTivic Health signals strategic transformation with $8.4M financing and biopharma focus amid market repositioningMay 16, 2025 | msn.comTivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comTivic Reports First Quarter 2025 Financial Results and Provides Updates on Business TransformationMay 15, 2025 | businesswire.comTivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA SubmissionMay 14, 2025 | finance.yahoo.comTivic adds new vagus nerve stim patentMay 13, 2025 | massdevice.comTivic Expands VNS Intellectual Property PortfolioMay 13, 2025 | businesswire.comTivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and WebcastMay 9, 2025 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTIVC, MHUA, INBS, and LYRA Company DescriptionsIntelligent Bio Solutions NASDAQ:INBS$2.13 +0.23 (+12.11%) Closing price 04:00 PM EasternExtended Trading$2.11 -0.02 (-0.94%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Lyra Therapeutics NASDAQ:LYRA$8.53 +0.05 (+0.59%) Closing price 04:00 PM EasternExtended Trading$8.29 -0.24 (-2.81%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.Meihua International Medical Technologies NASDAQ:MHUA$0.43 -0.01 (-1.14%) Closing price 03:59 PM EasternExtended Trading$0.43 0.00 (-0.72%) As of 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Tivic Health Systems NASDAQ:TIVC$3.95 +0.04 (+1.02%) Closing price 03:53 PM EasternExtended Trading$3.92 -0.03 (-0.63%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Rocket Lab Gets New Street-High Price Target from Citi Super Micro Stock May Benefit as Cooling Demand Takes Off Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings Salesforce Stock Set for 30% Upside to Reach New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
